Prevalence, Serotype Distribution, and Antimicrobial Resistance of Streptococcus agalactiae Among Pregnant Women in Greece: A Retrospective Study
Journal of Clinical Medicine · 20.08.2026 · 15 (16) · 6458
DOI: 10.3390/jcm15166458 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 20.08.2026. Verfasst von Anthia Chasiakou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopathology, Aretaieion University Hospital, National and Kapodistrian University of Athens, 76 Vassilisis Sofias Avenue, 11528 Athens…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Streptococcus agalactiae (group B Streptococcus, GBS) remains a leading cause of invasive infections in pregnant women, fetuses, and neonates. Universal screening at 36–37 weeks of gestation and intrapartum antimicrobial prophylaxis are essential to prevent adverse outcomes. This study aimed to determine the prevalence, serotype distribution, and antimicrobial susceptibility of GBS isolates among pregnant women in Greece.
Methods
Vaginal and rectal swabs were collected from pregnant women undergoing GBS screening between January 2021 and December 2025. Samples were processed using Todd-Hewitt broth with colistin and nalidixic acid, and cultured on blood agar and chromogenic media. The VITEK2 system was used for GBS identification and antimicrobial susceptibility testing against penicillin, erythromycin, clindamycin, tetracycline, levofloxacin, and vancomycin, according to EUCAST guidelines. The double-disk diffusion test was used for macrolide-lincosamide-streptogramin B (MLSB) phenotyping. Serotyping for all ten serotypes was conducted using a commercial latex agglutination assay.
Results
Among 941 women screened, 118 (12.5%) were colonized with GBS. The most prevalent serotypes were III (29.7%), V (18.6%), Ib (14.4%), IX (10.2%), Ia (9.3%), and II (9.3%). All isolates were susceptible to penicillin. Resistance to erythromycin and/or clindamycin was detected in 37 isolates. In these isolates, the predominant MLSB phenotype was constitutive (cMLSB, 78.4%), followed by inducible (iMLSB, 13.5%), L (5.4%), and M (2.7%) phenotypes.
Conclusions
GBS colonization was detected in 12.5% of pregnant women, with serotype III predominating, underscoring its clinical relevance due to its association with invasive neonatal disease. Although penicillin remains fully effective, the observed resistance to macrolides and lincosamides, primarily mediated by the cMLSB phenotype, raises concerns regarding alternative therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biopathology, Aretaieion University Hospital, National and Kapodistrian University of Athens, 76 Vassilisis Sofias Avenue, 11528 Athens, Greece.
- Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, 11527 Athens, Greece.
ORCID-Profile: Athanasios Tsakris
Zitieren
APA
Chasiakou, A., Kaparos, G., Chasiakou, S., Demeridou, S., Koumaki, V., & Tsakris, A. (2026). Prevalence, Serotype Distribution, and Antimicrobial Resistance of Streptococcus agalactiae Among Pregnant Women in Greece: A Retrospective Study. Journal of Clinical Medicine, 15(16), 6458. https://doi.org/10.3390/jcm15166458
Vancouver
Chasiakou A, Kaparos G, Chasiakou S, Demeridou S, Koumaki V, Tsakris A. Prevalence, Serotype Distribution, and Antimicrobial Resistance of Streptococcus agalactiae Among Pregnant Women in Greece: A Retrospective Study. Journal of Clinical Medicine. 2026;15(16):6458. doi:10.3390/jcm15166458
BibTeX
@article{Chasiakou2026,
author = {Chasiakou, Anthia and Kaparos, George and Chasiakou, Stamatia and Demeridou, Stiliani and Koumaki, Vasiliki and Tsakris, Athanasios},
title = {Prevalence, Serotype Distribution, and Antimicrobial Resistance of Streptococcus agalactiae Among Pregnant Women in Greece: A Retrospective Study},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {16},
pages = {6458},
doi = {10.3390/jcm15166458}
}
EUVIMED